143 related articles for article (PubMed ID: 9199476)
1. Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30.
Bast DJ; Sandhu J; Hozumi N; Barber B; Brunton J
Infect Immun; 1997 Jul; 65(7):2978-82. PubMed ID: 9199476
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
3. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
4. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
5. Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin.
Naito S; Horino A; Komiya T; Fukuda Y; Takahashi M; Ami Y; Suzaki Y; Satoh S; Gondaira F; Sugiyama J; Nakano Y; Mori M; Awai K; Nishinohara S; Komuro K; Uchida T
Int Arch Allergy Immunol; 1997 Nov; 114(3):293-7. PubMed ID: 9363912
[TBL] [Abstract][Full Text] [Related]
6. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.
Farkas-Himsley H; Hill R; Rosen B; Arab S; Lingwood CA
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6996-7000. PubMed ID: 7624357
[TBL] [Abstract][Full Text] [Related]
7. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
Clark C; Bast D; Sharp AM; St Hilaire PM; Agha R; Stein PE; Toone EJ; Read RJ; Brunton JL
Mol Microbiol; 1996 Feb; 19(4):891-9. PubMed ID: 8820657
[TBL] [Abstract][Full Text] [Related]
8. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
[TBL] [Abstract][Full Text] [Related]
9. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
10. Detection and production of verotoxin 1 of Escherichia coli O157:H7 in food.
Weeratna RD; Doyle MP
Appl Environ Microbiol; 1991 Oct; 57(10):2951-5. PubMed ID: 1746955
[TBL] [Abstract][Full Text] [Related]
11. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice.
Gemmell E; Winning TA; Grieco DA; Bird PS; Seymour GJ
J Periodontol; 2000 Jul; 71(7):1130-8. PubMed ID: 10960020
[TBL] [Abstract][Full Text] [Related]
12. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
13. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
14. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice.
Wolski VM; Soltyk AM; Brunton JL
Microb Pathog; 2002 Jun; 32(6):263-71. PubMed ID: 12137753
[TBL] [Abstract][Full Text] [Related]
16. Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit.
Ohmura M; Yamasaki S; Kurazono H; Kashiwagi K; Igarashi K; Takeda Y
Microb Pathog; 1993 Sep; 15(3):169-76. PubMed ID: 8271917
[TBL] [Abstract][Full Text] [Related]
17. Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies.
Byun Y; Ohmura M; Fujihashi K; Yamamoto S; McGhee JR; Udaka S; Kiyono H; Takeda Y; Kohsaka T; Yuki Y
Vaccine; 2001 Feb; 19(15-16):2061-70. PubMed ID: 11228378
[TBL] [Abstract][Full Text] [Related]
18. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of immune determinants of outer membrane proteins of Chlamydia psittaci strain guinea pig inclusion conjunctivitis.
Westbay TD; Dascher CC; Hsia RC; Bavoil PM; Zauderer M
Infect Immun; 1994 Dec; 62(12):5614-23. PubMed ID: 7525489
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.
Karmali MA; Petric M; Winkler M; Bielaszewska M; Brunton J; van de Kar N; Morooka T; Nair GB; Richardson SE; Arbus GS
J Clin Microbiol; 1994 Jun; 32(6):1457-63. PubMed ID: 8077389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
